These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 7700404)
21. [Experimental studies and clinical observations on the antifibrinolytic and hemostyptic effect of Epsilon-Tachostypan]. Egli H; Schröder F Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1968 May; 50(9):386-404. PubMed ID: 5252696 [No Abstract] [Full Text] [Related]
22. A bleeding tongue - acute presentation of fibrinolysis. Hodson A; Hunt BJ Int J Lab Hematol; 2007 Oct; 29(5):393-4. PubMed ID: 17824923 [No Abstract] [Full Text] [Related]
23. [Fibrinolytic hemorrhages in childhood and their therapy with PAMBA]. Hoffmann W; Mey U Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):88-93. PubMed ID: 4173887 [No Abstract] [Full Text] [Related]
24. [Fibrinolytic hemorrhage and antifibrinolytic preparations]. Panchenko M Klin Med (Mosk); 1969 Mar; 47(3):11-7. PubMed ID: 5406805 [No Abstract] [Full Text] [Related]
25. Comparative studies of the effect of fibrinolytic inhibitors (synthetic and naturally occurring substances) on coagulation and fibrinolytic systems in vitro and in vivo, and their clinical applications. Matsuoka M; Sakuragawa N; Yoneyama Y Acta Med Biol (Niigata); 1969 Mar; 16(3):105-20. PubMed ID: 4239124 [No Abstract] [Full Text] [Related]
26. [Clinical surgery and fibrinolysis]. Murakami F; Kadota H Saishin Igaku; 1966 Feb; 21(2):284-91. PubMed ID: 5966315 [No Abstract] [Full Text] [Related]
27. [Studies on the use of p-aminomethyl benzoic acid ethyl ester as antifibrinolytic agent]. Markwardt F; Klöcking HP; Vogel G Z Gesamte Inn Med; 1967 Oct; 22(19):569-74. PubMed ID: 5596621 [No Abstract] [Full Text] [Related]
28. May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency? Pozzi L; Della Valle P; D'Angelo A Blood Coagul Fibrinolysis; 2019 Jan; 30(1):52-53. PubMed ID: 30672814 [No Abstract] [Full Text] [Related]
29. [The use of PAMBA in urology]. Hellinger J Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):187-96. PubMed ID: 4174658 [No Abstract] [Full Text] [Related]
30. [The development of fibrinolysis inhibitors]. Markwardt F Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):5-14. PubMed ID: 4173881 [No Abstract] [Full Text] [Related]
31. [Experience with the clinical use of amben in hemorrhagic diathesis]. Larchenko GK Probl Gematol Pereliv Krovi; 1974; 19(5):59-61. PubMed ID: 4857434 [No Abstract] [Full Text] [Related]
36. [Hyperfibrinolytic hemorrhages in ENT practice and their with PAMBA]. Nuernbergk W Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):72-6. PubMed ID: 4173884 [No Abstract] [Full Text] [Related]
37. [Clinical experiences with p-aminomethylbenzoic acid (PAMBA) in severe acute fibrinolytic hemorrhage in internal medicine]. Sundermann A; Vogel G Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):22-31. PubMed ID: 4173877 [No Abstract] [Full Text] [Related]
38. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance. Carpenter SL; Mathew P Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165 [TBL] [Abstract][Full Text] [Related]
39. Fibrinolysis and its control. Andersson L S Afr Med J; 1972 Feb; 46(8):182-5. PubMed ID: 4260535 [No Abstract] [Full Text] [Related]
40. Haemostatic status in prostatectomy & the effect of para-aminomethyl benzoic acid on anti-fibrinolysis. Ambasta SS; Shukla KK; Dube RK; Dube B Indian J Med Res; 1988 Jul; 88():57-9. PubMed ID: 3263323 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]